Understanding Patient Experience Among Asians at MD Anderson
NCT ID: NCT06259253
Last Updated: 2025-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
520 participants
OBSERVATIONAL
2024-04-24
2030-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Benefits of Writing Therapy Among Asian American Cancer Survivors
NCT06367959
Positive Activities for Asian American Cancer Patients and Caregivers
NCT05203614
CARE Study: Cancer, Asian Americans, and Relationship Enrichment
NCT06782581
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study
NCT04754412
Facilitators and Barriers to Cancer Treatment Among Texas Residents
NCT07105046
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
a. Identify critical aspects of inpatient experience among former Asian/Asian American patients at MD Anderson.
Secondary Objectives:
a. Determine MD Anderson health care providers' perceptions of Asian/Asian American inpatient experience.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational Cohort 1 - Patient/Provider
Participant will complete a computer-based questionnaire about your age, gender, income, highest level of education, patient experience, medical mistrust, social support and health care access.
No interventions assigned to this group
Observational Cohort 2 - Patient/Provider
Participant will complete a computer-based questionnaire about your age, gender, income, highest level of education, patient experience, medical mistrust, social support and health care access.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are 18 years or older
* Have been diagnosed with cancer, any type
* Received inpatient care at MD Anderson between 2019 and 2022
* Have a U.S. address
* Can read and write in English or simplified Chinese
* Self-report as a practicing inpatient provider (advanced practice provider, hospitalist, physician, nurse) at MD Anderson
* Treated patients diagnosed with breast, colon, prostate, thyroid, or lymphatic cancer
* Provided treatment services to Asian/Asian American patients between 2019 and 2022
Exclusion Criteria
• None
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lorna McNeill, MPH,PHD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-00901
Identifier Type: REGISTRY
Identifier Source: secondary_id
2023-0521
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.